Windtree Therapeutics, Inc. (WINT)
OTCMKTS · Delayed Price · Currency is USD
0.0619
-0.0073 (-10.55%)
At close: Sep 11, 2025
Windtree Therapeutics Market Cap
Windtree Therapeutics has a market cap or net worth of $2.08 million as of September 11, 2025. Its market cap has decreased by -66.97% in one year.
Market Cap
2.08M
Enterprise Value
9.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since November 26, 1997, Windtree Therapeutics's market cap has decreased from 4.17B to 2.08M, a decrease of -99.95%. That is a compound annual growth rate of -23.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 10, 2025 | 2.33M | -39.69% |
Dec 31, 2024 | 3.86M | 4.27% |
Dec 29, 2023 | 3.70M | -43.61% |
Dec 30, 2022 | 6.56M | -85.53% |
Dec 31, 2021 | 45.36M | -47.74% |
Dec 31, 2020 | 86.80M | -50.07% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 982.68M |
Veradigm | 781.22M |
Elite Pharmaceuticals | 736.80M |
Tian'an Technology Group | 732.84M |
Glass House Brands | 585.86M |
Northwest Biotherapeutics | 376.88M |
CytoDyn | 367.97M |
American Oncology Network | 346.29M |